Shizhe Ding is the founder of E-nitiate Biopharmaceuticals. E-nitiate Biopharmaceuticals has raised $14M in total funding. Latest round: Series A.
Shizhe Ding is the CEO of E-nitiate Biopharmaceuticals. The company, founded in late 2020, focuses on developing innovative drugs for dermatology and autoimmune diseases. E-nitiate Biopharmaceuticals recently completed a Series A financing round of 100 million RMB (US$14.4 million) to advance the clinical development of its pipelines, including QY201 and QY101.
Full founder directory · Investor directory · Company funding database · Fundraising library